Precigen (PGEN) stock is experiencing a significant surge in Friday's pre-market trading, jumping 5.56% following the release of its better-than-expected first-quarter earnings report. The biotechnology company's positive financial results have caught investors' attention, driving the stock's upward momentum.

The company's strong performance is not only attributed to its financial results but also to the progress made on its lead asset, PRGN-2012. Precigen has been making strides towards commercializing this product, which has further boosted investor confidence in the company's future prospects.

Analysts have expressed bullish sentiments on Precigen stock, citing the positive developments in the company's pipeline. The combination of solid financial performance and advancements in key projects appears to be fueling the stock's impressive gain. As the trading day progresses, investors will be closely watching to see if Precigen can maintain this upward trajectory.